Literature DB >> 7856734

Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.

G P Boivin1, B A O'Toole, I E Orsmby, R J Diebold, M J Eis, T Doetschman, A B Kier.   

Abstract

Null-mutant (knockout) mice were obtained through disruption of the sixth exon of the endogenous transforming growth factor-beta 1 allele in murine embryonic stem cells via homologous recombination. Mice lacking transforming growth factor-beta 1 (mutants) were born grossly indistinguishable from wild-type littermates. With time, mutant mice exhibited a wasting phenotype that manifested itself in severe weight loss and dishevelled appearance (between 15 and 36 days of age). Examination of these moribund mice histologically revealed that transforming growth factor-beta 1-deficient mice exhibit a moderate to severe, multifocal, organ-dependent, mixed inflammatory cell response adversely affecting the heart, stomach, diaphragm, liver, lung, salivary gland, and pancreas. Because of the known multifunctional nature of transforming growth factor-beta 1 on the control of growth and differentiation of many different cell types, it is important to determine the degree to which the inflammatory response interacts with or masks other deficiencies that are present. To this end, we examined the extent and nature of the inflammatory lesions in different ages of neonatal knockout mice (5, 7, 10, and 14 days of age) and older moribund mice (> 15 days of age) and compared them with the histology seen in wild-type normal animals. Mild inflammatory infiltrates were first observed in 5-day mutant mice in the heart, by day 7 in the lung, salivary gland, and pancreas, and by day 14 inflammatory lesions were found in almost all organs examined. Moderate to severe inflammation was not present until the mice were 10 to 14 days old. In the older animals, there was a slight increase in the severity of the inflammatory lesions as the mice aged.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856734      PMCID: PMC1870775     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

Review 1.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation.

Authors:  M Laiho; J A DeCaprio; J W Ludlow; D M Livingston; J Massagué
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

Review 3.  The cell biology of transforming growth factor beta.

Authors:  J A Barnard; R M Lyons; H L Moses
Journal:  Biochim Biophys Acta       Date:  1990-06-01

4.  Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.

Authors:  A B Glick; A B Kulkarni; T Tennenbaum; H Hennings; K C Flanders; M O'Reilly; M B Sporn; S Karlsson; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

5.  Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice.

Authors:  K L Hines; A B Kulkarni; J B McCarthy; H Tian; J M Ward; M Christ; N L McCartney-Francis; L T Furcht; S Karlsson; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers.

Authors:  C Ciacci; S E Lind; D K Podolsky
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

7.  Maternal rescue of transforming growth factor-beta 1 null mice.

Authors:  J J Letterio; A G Geiser; A B Kulkarni; N S Roche; M B Sporn; A B Roberts
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

Review 8.  Transforming growth factor beta: possible roles in the regulation of normal and leukemic hematopoietic cell growth.

Authors:  J R Keller; G K Sing; L R Ellingsworth; F W Ruscetti
Journal:  J Cell Biochem       Date:  1989-02       Impact factor: 4.429

9.  Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.

Authors:  T Espevik; I S Figari; M R Shalaby; G A Lackides; G D Lewis; H M Shepard; M A Palladino
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

10.  Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.

Authors:  S C Wallick; I S Figari; R E Morris; A D Levinson; M A Palladino
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  30 in total

Review 1.  The role of TGF-beta in patterning and growth of the mammary ductal tree.

Authors:  C W Daniel; S Robinson; G B Silberstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

2.  Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling.

Authors:  Chunsun Dai; Xiaoyan Wen; Weichun He; Youhua Liu
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissues.

Authors:  T Nakabayashi; K M Sakata; A Sakata; L Kong; C A Lau; J J Letterio; N Vela-Roch; N Talal; H Dang
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

4.  Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response.

Authors:  Yunjeong Jo; Sang Uk Han; Yoon Jae Kim; Ju Hyeon Kim; Shin Tae Kim; Seong-Jin Kim; Ki-Baik Hahm
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

5.  Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.

Authors:  J J Letterio; A G Geiser; A B Kulkarni; H Dang; L Kong; T Nakabayashi; C L Mackall; R E Gress; A B Roberts
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 6.  Pathogenesis of juvenile chronic arthritis: genetic and environmental factors.

Authors:  K Murray; S D Thompson; D N Glass
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

Review 7.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

8.  Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions.

Authors:  G P Boivin; I Ormsby; J Jones-Carson; B A O'Toole; T Doetschman
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

Review 9.  Cell signaling regulation in salivary gland development.

Authors:  Akiko Suzuki; Kenichi Ogata; Junichi Iwata
Journal:  Cell Mol Life Sci       Date:  2021-01-15       Impact factor: 9.261

10.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.